Sea Pharmaceuticals, LLC — SEC Form D Filing

Sea Pharmaceuticals, LLC filed an SEC Form D on May 20, 2026, reporting $71K raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
May 20, 2026
Amount reported
$71K
Industry
Pharmaceuticals
Website
https://www.seapharmaceuticals.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: IOWA

Problem

There is a need for effective treatments for Tinnitus, Epilepsy, and Sporadic ALS.

Solution

Sea Pharmaceuticals is developing proprietary synthetic small molecule treatments for Tinnitus, Epilepsy, and Sporadic ALS.

Verdict

Investors were likely persuaded to invest in Sea Pharmaceuticals due to the pressing need for effective treatments for Tinnitus, Epilepsy, and Sporadic ALS, which positioned the company at the intersection of high unmet medical needs. This cleared because the narrative centered around addressing significant health issues, not because of established advantage or market presence. However, the limited upside lies in the fact that without a clear plan to differentiate from competitors developing similar treatments, the long-term viability of the investment remains uncertain.

Source: SEC EDGAR Form D filing